RCM
NVRO

Rotella Capital Management’s NEVRO CORP. NVRO Stock Holding History

Rotella Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,800
Closed -$204K – 678
2015
Q2 		$204K Buy
+3,800
New +$194K 0.17% 162

Other funds holding NVRO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

Rotella Capital Management's NVRO Position: Q3 2015 in Review

Rotella Capital Management sold out of NEVRO CORP. (NVRO) in Q3 2015, closing a stake of 3,800 shares — an estimated $204K sold.

Rotella Capital Management first reported a position in NVRO in Q2 2015 and held it in 1 quarter. The position peaked at $204K in Q2 2015. 107 funds tracked by Wall St. Rank hold NVRO as of Q3 2015.

  • Rotella Capital Management reported no remaining NEVRO CORP. position as of Q3 2015 after selling out during the quarter.
  • Rotella Capital Management sold 3,800 NEVRO CORP. shares in Q3 2015, an estimated $204K.
  • Rotella Capital Management first reported a position in NEVRO CORP. in Q2 2015 and held it in 1 quarter.
  • Rotella Capital Management's NEVRO CORP. position peaked at $204K in Q2 2015.
  • 107 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2015.

Based on Rotella Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.